ImClone Investigational Site

Metairie, Louisiana 70006-2921

0 studies enrolling now · 10 studies all time

What they study most

Adipocytic Sarcoma, Cancer, Colorectal Cancer, Colorectal Neoplasms, Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Fallopian Tube Cancer, Hepatocellular Carcinoma, Leiomyosarcoma, Metastases, Metastatic Pancreatic Cancer, Metastatic Renal Cell Carcinoma, Neoplasm

Studies at this site

• Study of Ramucirumab in Ovarian Cancer — Completed
• A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma — Completed
• A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver — Completed
• Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes — Completed
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy — Completed
• A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma — Completed
• Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer — Stopped early
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed